Pennington, NJ, United States of America

Min Shen


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):

Title: Unveiling the Innovation of Min Shen: Revolutionizing Cancer Treatment

Introduction: Min Shen, a distinguished inventor based in Pennington, NJ (US), has made significant strides in the field of oncology with his groundbreaking patent on O-linked pyrimidin-4-amine-based compounds. His exceptional work at Lexicon Pharmaceuticals, Inc. has positioned him as a trailblazer in the fight against cancer.

Latest Patents: Min Shen holds a remarkable patent for O-linked pyrimidin-4-amine-based compounds, pharmaceutical compositions comprising them, and methods of their use in cancer treatment. The specific compounds of this invention, encompassed by formula I, showcase his innovative approach to developing novel therapies for combating cancer.

Career Highlights: With a primary focus on oncology research, Min Shen has demonstrated unparalleled dedication and expertise in the pharmaceutical industry. His tenure at Lexicon Pharmaceuticals, Inc. has been marked by a commitment to advancing the frontiers of cancer treatment through cutting-edge innovations.

Collaborations: Collaborating closely with esteemed colleagues such as David John Augeri and Marianne Carlsen, Min Shen has fostered a collaborative environment conducive to fostering innovation and driving progress in the fight against cancer. Together, they form a formidable team dedicated to transforming the landscape of oncology research.

Conclusion: In conclusion, Min Shen's pioneering work in the development of O-linked pyrimidin-4-amine-based compounds for cancer treatment exemplifies his unwavering commitment to innovation and scientific advancement. His contributions have undoubtedly left an indelible mark on the field of oncology, offering hope to countless individuals battling this formidable disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…